International meeting focused on Hepatitis B virus research
Official title: 2024 International Meeting on the Molecular Biology of Hepatitis B Viruses (International HBV Meeting)
Funded at Hepatitis B Foundation · NIH-10999579 · Data updated 2026-11-12
This study is bringing together scientists from around the world to share ideas and discoveries about Hepatitis B, with a focus on finding better treatments, especially by including diverse voices in the conversation.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Hepatitis B Foundation NIH-funded |
| Lab location | 1 site (Doylestown, United States) |
| Project start | August 6, 2024 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $5,000 |
| NIH project number | 1R13AI186428-01 |
| Project ID | NIH-10999579 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research are individuals affected by chronic Hepatitis B or those interested in the latest advancements in HBV treatment.
✕Less likely to help
Patients who are not affected by Hepatitis B or who are not involved in research or clinical trials related to HBV may not receive any benefit from this research.
What this research studies
This research involves organizing an international meeting that brings together scientists and researchers to discuss advancements in understanding and treating Hepatitis B virus (HBV) infections. The meeting aims to foster collaboration and knowledge sharing among established and early career researchers, particularly those from underrepresented backgrounds. It will cover topics such as infection mechanisms, disease progression, and potential therapeutic strategies for chronic HBV. By facilitating discussions and presentations, the meeting seeks to accelerate the development of new treatments for HBV.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that improve outcomes for patients with chronic Hepatitis B infections.
How similar studies have gone: Previous international meetings on similar topics have successfully fostered collaboration and led to advancements in the understanding and treatment of Hepatitis B.
Where this research is happening
-
Hepatitis B Foundation
Doylestown, United States Active
Researchers
- Principal investigator: Ploss, Alexander — Hepatitis B Foundation
- Study coordinator: Ploss, Alexander
Related research
Other NIH-funded projects on the same topics.
-
HBV cure clues in people with and without HIV
This project studies how HBV-specific B and T cell responses relate to curing hepatitis B in people with and without HIV.
-
HBV cure factors in people with and without HIV
This project studies how HBV-specific immune cells behave during treatment and whether people with HIV respond differently than those without HIV.
-
HBV prevention in community pharmacies: a first step in a low-resource setting
This pilot project tests whether hepatitis B screening and vaccination can be integrated into everyday community pharmacy services to reach more people.
-
Blood markers to catch early liver cancer in Hispanic people with hepatitis B
This project will see if a blood test can find liver cancer earlier in Hispanic people who have chronic hepatitis B.
-
Early blood markers to find hepatitis B–related liver cancer in Hispanics
This project will use immune-related blood markers to find liver cancer earlier in people with chronic hepatitis B, focusing on Hispanic adults.
-
HBV safety with long-acting HIV therapy for people with HIV
A study to understand how long-acting HIV meds affect hepatitis B in people living with HIV and how to best monitor and protect them.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.